| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.16B | 48.01B | 47.29B | 42.82B | 38.61B | 43.96B |
| Gross Profit | 10.20B | 11.16B | 10.06B | 9.49B | 8.63B | 8.93B |
| EBITDA | 2.95B | 3.63B | 2.85B | 2.32B | 1.93B | 2.56B |
| Net Income | 1.84B | 2.27B | 1.77B | 1.21B | 1.10B | 1.49B |
Balance Sheet | ||||||
| Total Assets | 19.49B | 21.98B | 20.19B | 18.08B | 16.94B | 16.10B |
| Cash, Cash Equivalents and Short-Term Investments | 5.53B | 7.48B | 5.97B | 3.77B | 3.25B | 2.51B |
| Total Debt | 370.00M | 4.00M | 399.00M | 654.00M | 1.07B | 1.61B |
| Total Liabilities | 7.33B | 8.07B | 8.23B | 7.66B | 7.53B | 7.56B |
| Stockholders Equity | 12.05B | 13.79B | 11.84B | 10.32B | 9.32B | 8.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.16B | 2.70B | 1.14B | 1.54B | 758.00M |
| Operating Cash Flow | 0.00 | 3.00B | 2.94B | 1.43B | 1.83B | 996.00M |
| Investing Cash Flow | 0.00 | -2.13B | -604.00M | -316.00M | -710.00M | -606.00M |
| Financing Cash Flow | 0.00 | -724.00M | -498.00M | -628.00M | -771.00M | -816.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥10.57B | 4.47 | ― | 2.48% | 1.53% | 28.36% | |
74 Outperform | ¥202.85B | 5.88 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥55.32B | 14.67 | ― | 4.12% | 6.27% | 31.76% | |
64 Neutral | ¥40.20B | 8.77 | ― | 5.16% | 1.23% | -22.74% | |
62 Neutral | ¥13.10B | 9.34 | ― | 4.62% | -0.44% | -13.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥47.44B | 32.39 | 1.55% | 1.34% | -14.56% | 181.24% |